About
Channel Lab specializes in developing telemedicine applications and certified medical devices aimed at the early detection of severe diseases. Their focus is on creating robust datasets for machine learning, which support their products designed to identify diseases at early stages. The company collaborates with research institutions, universities, and hospitals to ensure the efficacy and reliability of their offerings. One of their notable products is Aireen, a certified telemedical device that screens for severe eye diseases like diabetic retinopathy, glaucoma, and age-related macular degeneration by analyzing retinal images. Aireen utilizes AI models that have been validated by leading ophthalmologists and diabetologists, addressing the shortage of specialists and reducing diagnosis time. Channel Lab's services and products are targeted at healthcare providers, medical researchers, and institutions involved in disease screening and early diagnosis. They emphasize clinical validation and invite collaboration and investment opportunities to further enhance their telemedicine solutions.
Technologies
Keywords
Company Information
-
Employees 7
-
Founded 2020
Location
Czech Republic